Pete, the first dose is, according to Doc Feelgood, very small. It is the ACCELERATION of the amount of dosing that is fast. (The step-up doses will be increased faster than usual). Therefore I do not expect there to be any therapeutic results with the first cohort. Also we are dealing with a major world-class institution. Data analysis could take much longer than we think/hope because no one wants to take a chance on either releasing something that turns out to be wrong, or being criticized for releasing meaningless data points. So I am not holding my breath -- I think this will go slowly but the move will be explosive when it comes.